
Winbrio Pharmaceuticals LLP
About Winbrio Pharmaceuticals LLP
Data last updated:
Winbrio Pharmaceuticals LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 24 December 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAR-3999.
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Shantaram Ganapat Kadam and Pradnya Kiran Ghodke.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No. 532 Sector No. 21 Near Nana Nani Park Yamuna Nagar Pcntda Nigdi, Pune, Maharashtra, India – 411044.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 532 Sector No. 21 Near Nana Nani Park Yamuna Nagar Pcntda Nigdi, Pune, Maharashtra, India – 411044
- IndustryChemicals, Chemicals and Chemical Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Winbrio Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Winbrio Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Winbrio Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Winbrio Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Winbrio Pharmaceuticals LLP
Winbrio Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shantaram Ganapat Kadam | Designated Partner | 24 Dec 2019 | 6 Years 9 Months | Current |
| Pradnya Kiran Ghodke | Designated Partner | 24 Dec 2019 | 6 Years 9 Months | Current |
Charges & Borrowings of Winbrio Pharmaceuticals LLP
Winbrio Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Winbrio Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Winbrio Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Winbrio Pharmaceuticals LLP
Winbrio Pharmaceuticals LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Pradnya Kiran Ghodke was appointed as Designated Partner on 24 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Winbrio Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Winbrio Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Winbrio Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Winbrio Pharmaceuticals LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Winbrio Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Winbrio Pharmaceuticals LLP
Winbrio Pharmaceuticals is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 24 December 2019 (7+ years old) and is registered under LLPIN AAR-3999.
Winbrio Pharmaceuticals has 2 current designated partners:
- Shantaram Ganapat Kadam - Designated Partner
- Pradnya Kiran Ghodke - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Winbrio Pharmaceuticals is AAR-3999. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Winbrio Pharmaceuticals was incorporated on 24 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Pradnya Kiran Ghodke was appointed as Designated Partner on 24 Dec 2019. Shantaram Ganapat Kadam was appointed as Designated Partner on 24 Dec 2019.
The registered office of Winbrio Pharmaceuticals is at Plot No. 532 Sector No. 21 Near Nana Nani Park Yamuna Nagar Pcntda Nigdi, Pune, Maharashtra, India – 411044.
The total obligation of contribution is ₹50,000.
Winbrio Pharmaceuticals operates in the chemicals industry, in the chemicals and chemical products segment.
Winbrio Pharmaceuticals can be reached at its registered office: Plot No. 532 Sector No. 21 Near Nana Nani Park Yamuna Nagar Pcntda Nigdi, Pune, Maharashtra, India – 411044.
Winbrio Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.